Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | ABBV:NYQ since announced | Transaction value |
---|---|---|
Aliada Therapeutics Inc | -8.43% | 1.40bn |
Celsius Therapeutics Inc | 0.50% | 250.00m |
Cerevel Therapeutics Holdings Inc | 18.98% | 8.70bn |
ImmunoGen Inc | 24.19% | 10.22bn |
Data delayed at least 15 minutes, as of Nov 21 2024 19:15 GMT.